Expression of human TIM-3 and its correlation with disease activity in rheumatoid arthritis

Scandinavian Journal of Rheumatology

Volumn 40, Issue 5, 2011, Pages 334-340

  Lee, J ^a,b   Oh, J M ^a,b   Hwang, J W ^a,b   Ahn, J K ^a,c   Bae, E K ^a,d   Won, J ^e   Koh, E M ^a,b   Cha, H S ^a,b  

^a Sungkyunkwan University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Samsung Medical Center   (South Korea)

^e Mogam Biotechnology Research Institute   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ECALECTIN; GAMMA INTERFERON; INTERLEUKIN 17; KIDNEY INJURY MOLECULE 1; KIDNEY INJURY MOLECULE 3; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; MALE; NUCLEOTIDE SEQUENCE; OSTEOARTHRITIS; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIUM;

ADULT; AGED; ARTHRITIS, RHEUMATOID; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GALECTINS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MEMBRANE PROTEINS; MIDDLE AGED; OSTEOARTHRITIS; SEVERITY OF ILLNESS INDEX; SYNOVIAL FLUID;

EID: 80051937349     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2010.547871     Document Type: Article

References (26)

1. Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, Chernova T, et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 2002;415:536-41. (Pubitemid 34130609)
2. Sanchez-Fueyo A, Tian J, Picarella D, Domenig C, Zheng XX, Sabatos CA, et al. Tim-3 inhibits T helper type 1-mediated autoand alloimmune responses and promotes immunological tolerance. Nat Immunol 2003;4:1093-101. (Pubitemid 37428037)
3. Anderson AC, Anderson DE. TIM-3 in autoimmunity. Curr Opin Immunol 2006;18:665-9. (Pubitemid 44635179)
4. Chen Y, Langrish CL, McKenzie B, Joyce-Shaikh B, Stumhofer JS, McClanahan T, et al.Anti-IL-23 therapy inhibitsmultiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest 2006;116:1317-26.
5. Nakae S, Iwakura Y, Suto H, Galli SJ. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leukoc Biol 2007;81:1258-68. (Pubitemid 46702045)
6. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ, et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 2005;6:1245-52. (Pubitemid 43045636)
7. Seki M, Oomizu S, Sakata KM, Sakata A, Arikawa T, Watanabe K, et al. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol 2008;127:78-88.
8. Chae SC, Park YR, Shim SC, Yoon KS, Chung HT. The polymorphisms of Th1 cell surface gene Tim-3 are associated in a Korean population with rheumatoid arthritis. Immunol Lett 2004;95:91-5.
9. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
10. Klippel JH, Stone JH, Crofford LJ, White PH. Primer on the rheumatic diseases. 13th edn. Atlanta, GA: Arthritis Foundation, 2008.
11. Asakura H, Kashio Y, Nakamura K, Seki M, Dai S, Shirato Y, et al. Selective eosinophil adhesion to fibroblast via IFN-gamma-induced galectin-9. J Immunol 2002;169:5912-18. (Pubitemid 35291697)
12. Imaizumi T, Kumagai M, Sasaki N, Kurotaki H, Mori F, Seki M, et al. Interferon-gamma stimulates the expression of galectin-9 in cultured human endothelial cells. J Leukoc Biol 2002;72:486-91.
13. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-73. (Pubitemid 19138011)
14. Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 1999;103:1345-52. (Pubitemid 29218305)
15. Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, et al. Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 1999;42:963-70. (Pubitemid 29215007)
16. Ziolkowska M, Koc A, Luszczykiewicz G, Ksiezopolska-Pietrzak K, Klimczak E, Chwalinska-Sadowska H, et al. High levels of IL- 17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol 2000;164:2832-8. (Pubitemid 30115519)
17. Seki M, Sakata KM, Oomizu S, Arikawa T, Sakata A, Ueno M, et al. Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts. Arthritis Rheum 2007;56:3968-76. (Pubitemid 350262324)
18. Khademi M, Illes Z, Gielen AW, Marta M, Takazawa N, Baecher- Allan C, et al. T cell Ig- and mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis. J Immunol 2004;172:7169-76. (Pubitemid 38669161)
19. Koguchi K, Anderson DE, Yang L, O'Connor KC, Kuchroo VK, Hafler DA. Dysregulated T cell expression of TIM3 in multiple sclerosis. J Exp Med 2006;203:1413-18. (Pubitemid 43877603)
20. Saita N, Goto E, Yamamoto T, Cho I, Tsumori K, Kohrogi H, et al. Association of galectin-9 with eosinophil apoptosis. Int Arch Allergy Immunol 2002;128:42-50. (Pubitemid 34621665)
21. Kageshita T, Kashio Y, Yamauchi A, Seki M, Abedin MJ, Nishi N, et al. Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance. Int J Cancer 2002;99:809-16. (Pubitemid 34575697)
22. Wada J, Ota K, Kumar A, Wallner EI, Kanwar YS. Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin. J Clin Invest 1997;99:2452-61. (Pubitemid 27227724)
23. Matsumoto R, Matsumoto H, SekiM, Hata M, Asano Y, Kanegasaki S, et al. Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. J Biol Chem 1998;273:16976-84. (Pubitemid 28311730)
24. Kashio Y, Nakamura K, Abedin MJ, Seki M, Nishi N, Yoshida N, et al. Galectin-9 induces apoptosis through the calcium-calpaincaspase-1 pathway. J Immunol 2003;170:3631-6. (Pubitemid 36359232)
25. Wang F, Wan L, Zhang C, Zheng X, Li J, Chen ZK. Tim-3-galectin- 9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells. Immunobiology 2009;214:342-9.
26. Ryder LR, Woetmann A, Madsen HO, Odum N, Ryder LP, Bliddal H, et al. Expression of full-length and splice forms of FoxP3 in rheumatoid arthritis. Scand J Rheumatol 2010; 39:279-86.